|
MRPL10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.11869999999981E-05 |
| Normal-vs-Stage3 |
1.85200000002439E-06 |
| Normal-vs-Stage4 |
5.79349999999534E-05 |
| Stage1-vs-Stage2 |
6.051600E-01 |
| Stage1-vs-Stage3 |
8.198400E-01 |
| Stage1-vs-Stage4 |
2.329600E-02 |
| Stage2-vs-Stage3 |
7.835800E-01 |
| Stage2-vs-Stage4 |
9.034400E-02 |
| Stage3-vs-Stage4 |
4.556100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.349054532644E-12 |
| Normal-vs-Asian |
5.385900E-02 |
| Caucasian-vs-AfricanAmerican |
2.167200E-01 |
| Caucasian-vs-Asian |
8.183600E-01 |
| AfricanAmerican-vs-Asian |
4.801000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.18325357792537E-12 |
| Male-vs-Female |
7.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.02359999657409E-08 |
| Normal-vs-Extreme_Weight |
3.03090885722668E-13 |
| Normal-vs-Obese |
2.92543766988729E-12 |
| Normal-vs-Extreme_Obese |
7.537600E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.651000E-01 |
| Normal_Weight-vs-Obese |
6.182600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.906000E-01 |
| Extreme_Weight-vs-Obese |
9.115800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.041800E-01 |
| Obese-vs-Extreme_Obese |
5.284000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203380E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.675900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.988200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.069680E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.696800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.915500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.002450E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.456790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
7.02299995936073E-10 |
| Normal-VS-KIRP CIMP |
3.244800E-04 |
| Normal-VS-Unclassified PRCC |
2.4759999999957E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.605200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.815500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.063600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.203700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.145800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.132580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40039999596553E-08 |
| Normal-vs-N1 |
3.90200000000007E-06 |
| Normal-vs-N2 |
3.863700E-02 |
| N0-vs-N1 |
8.692000E-01 |
| N0-vs-N2 |
4.999300E-03 |
| N1-vs-N2 |
4.900000E-03 |
|
|
